11th Annual Oncology Innovation Forum

Following a successful history, Sachs Associates, with the support of its partners, has decided to move the dates of the 11th Annual Oncology Innovation Forum (#Sachs_OIF) to coincide with the JP Morgan Healthcare Week rather than the ASCO meeting. This strategic shift is intended to enable greater participation from the investor community attending during that week. The forum will take place on the 10th of January 2026, a day before the 9th Annual Neuroscience Innovation Forum (#Sachs_NIF), allowing relevant attendees the opportunity to register for both events. The Virtual Week will follow from the 20th – 22nd of January.  
  
The 11th Annual OIF offers a well-established networking platform for senior executives from biotech to meet with pharma licensing teams, corporate and financial investors, and industry advisers. Meetings will run alongside a dynamic programme focused on current trends in pharma-biotech dealmaking, including Chinese deal flow, and investment opportunities across a broad range of therapeutic targets and modalities. All company showcases and panel discussions will be recorded and made available on demand for the virtual audience the week after JPM. The forum will also feature pre-arranged in-person and virtual meetings, live and on-demand company presentations, and a networking reception. 
 
The event brings together leaders from cancer research institutes, pharma, biotech, and Wall Street, to facilitate partnering, funding, and investment. We anticipate 250+ delegates and 20+ company presentations by established and emerging companies with part of the audience participating virtually. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand. Recorded sessions will also be added on demand on the event portal during the virtual week.